SARS-CoV-2 vaccinations are accelerating across the U.S. with approximately 66 million first doses having been administered as of February 25th, representing 13.6% of the country, according to NPR. The vaccination effort received another boost with the Food and Drug Administration’s recent Emergency Use Authorization (EUA) of Johnson & Johnson’s (J&J) single-dose vaccine.
Image: https://biobuzz.io
{iframe}https://biobuzz.io/emergent-biosolutions-seeks-new-talent-to-support-global-covid-19-vaccination-push-expanding-project-portfolio/{/iframe}